Adicet Bio Announces Completion Of Last Patient Visit For 22-Patient Phase 1 Analysis Of Prula-Cel In Systemic Lupus Erythematosus; Says Topline Data Expected September 2026
Share
Why It Matters
A medicine company finished testing a new treatment for a serious disease on 22 sick people—the first step to see if it's safe and works. Now we wait until September 2026 to hear what they learned, which will help us understand if this medicine might actually help patients.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.